- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Results
6
Companies which have announced upcoming dividend payments.
6 companies
Essex Bio-Technology
Market Cap: HK$1.3b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.26
7D
-4.0%
1Y
-61.1%
Jacobson Pharma
Market Cap: HK$2.1b
Through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally.
2633
HK$1.06
7D
2.4%
1Y
-29.3%
Pak Fah Yeow International
Market Cap: HK$771.3m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.48
7D
3.3%
1Y
3.3%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.
2161
HK$1.91
7D
3.5%
1Y
-37.9%
Sino Biopharmaceutical
Market Cap: HK$99.6b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$5.58
7D
16.0%
1Y
-33.3%
CSPC Pharmaceutical Group
Market Cap: HK$105.1b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.40
7D
7.3%
1Y
-13.4%